Denali Therapeutics Inc. (DNLI)
USD 12.79
(1.87%)
USD 12.79
(1.87%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -357.99 Million | -244.71 Million | -211.38 Million | 416.15 Million | -151.57 Million | 50.11 Million |
| Net Income | -145.22 Million | -325.99 Million | -290.58 Million | 71.13 Million | -197.61 Million | -36.24 Million |
| Depreciation & Amortization | 16.72 Million | 10.38 Million | 8.59 Million | 8.53 Million | 7.99 Million | 7.41 Million |
| Deferred income taxes | -2.43 Million | - | 8.74 Million | 55 Thousand | -5.01 Million | - |
| Stock-based compensation | 108.1 Million | 99.84 Million | 85.24 Million | 50.35 Million | 38.37 Million | 18.79 Million |
| Change in working capital | -289.92 Million | -24.03 Million | -20.41 Million | 288.4 Million | 4.17 Million | 62.89 Million |
| Other non-cash items | -45.23 Million | -4.92 Million | -2.98 Million | -2.32 Million | 513 Thousand | -2.74 Million |
| Investing Cash Flow | 249.3 Million | -141.38 Million | -21.62 Million | -623.2 Million | 147.71 Million | -287.42 Million |
| Investments in PPE | -12.93 Million | -17.83 Million | -8.5 Million | -3.09 Million | -17.91 Million | -3.39 Million |
| Acquisitions | -262.24 Million | 123.55 Million | 13.12 Million | 620.11 Million | -165.63 Million | - |
| Investment purchases | -1.81 Billion | -1.11 Billion | -1.42 Billion | -1.28 Billion | -369.69 Million | -557.93 Million |
| Sales/Maturities of investments | 2.07 Billion | 991.48 Million | 1.4 Billion | 665.35 Million | 535.32 Million | 273.9 Million |
| Other Investing Activities | 262.24 Million | -123.55 Million | -13.12 Million | -620.11 Million | 165.63 Million | -284.02 Million |
| Financing Cash Flow | 17.82 Million | 310.67 Million | 19.34 Million | 634.74 Million | 6.19 Million | 97.01 Million |
| Debt repayment | - | -3.14 Million | -3.73 Million | -297.41 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 17.82 Million | 296.21 Million | 19.34 Million | 614.09 Million | 6.19 Million | 97.01 Million |
| Other Financing Activities | 17.82 Million | 17.6 Million | 3.73 Million | 318.07 Million | 6.19 Million | 97.01 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 2.43 Million | 2.27 Million | 3.7 Million | -1.62 Million | 1.03 Million | -526 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -292.35 Million | -26.3 Million | -24.11 Million | 290.02 Million | 3.14 Million | 63.41 Million |
| Cash at beginning of period | 218.04 Million | 294.97 Million | 508.64 Million | 80.94 Million | 78.62 Million | 218.91 Million |
| Cash at end of period | 127.1 Million | 219.54 Million | 294.97 Million | 508.64 Million | 80.94 Million | 78.62 Million |
| Capital Expenditure | -12.93 Million | -17.83 Million | -8.5 Million | -3.09 Million | -17.91 Million | -3.39 Million |
| Effect of forex changes on cash | -75 Thousand | - | - | - | - | - |
| Net cash flow / Change in cash | -90.93 Million | -75.43 Million | -213.66 Million | 427.69 Million | 2.32 Million | -140.28 Million |
| Free Cash Flow | -370.93 Million | -262.54 Million | -219.88 Million | 413.05 Million | -169.49 Million | 46.72 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -99.02 Million | -101.8 Million | -119.47 Million | -145.22 Million | -99.35 Million | 183.38 Million |
| Depreciation & Amortization | 1.94 Million | 2.16 Million | 2.17 Million | 16.72 Million | 2.21 Million | 2.28 Million |
| Deferred income taxes | - | - | -32.42 Million | -2.43 Million | -12.32 Million | -11.53 Million |
| Stock-based compensation | 25.1 Million | 27.84 Million | 25.98 Million | 108.1 Million | 27.46 Million | 26.57 Million |
| Change in working capital | -8.15 Million | -15.81 Million | 5.84 Million | -289.92 Million | -4.4 Million | -312.94 Million |
| Other non-cash items | 14.01 Million | 5.51 Million | 19.22 Million | -45.23 Million | -957 Thousand | -928 Thousand |
| Investing Cash Flow | 98.56 Million | -453.18 Million | 73.04 Million | 249.3 Million | 100.9 Million | 168.06 Million |
| Investments in PPE | -4.78 Million | -2.15 Million | -2.23 Million | -12.93 Million | -2.06 Million | -5.85 Million |
| Acquisitions | - | - | -75.28 Million | -262.24 Million | -102.97 Million | -173.91 Million |
| Investment purchases | -121.64 Million | -834.15 Million | -413.71 Million | -1.81 Billion | -498.14 Million | -378.12 Million |
| Sales/Maturities of investments | 225 Million | 383.12 Million | 489 Million | 2.07 Billion | 601.11 Million | 552.04 Million |
| Other Investing Activities | 103.35 Million | -451.03 Million | 75.28 Million | 262.24 Million | 102.97 Million | 173.91 Million |
| Financing Cash Flow | 6.75 Million | 500.27 Million | 4.7 Million | 17.82 Million | 2.49 Million | 9.01 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 6.75 Million | 500.27 Million | 4.7 Million | 17.82 Million | 2.49 Million | 9.01 Million |
| Other Financing Activities | 6.75 Million | 1.02 Million | 4.7 Million | 17.82 Million | 2.49 Million | 9.01 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 3.88 Million | 635 Thousand | -2.08 Million | 2.43 Million | -3.96 Million | 4.77 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -12.04 Million | -16.44 Million | 7.93 Million | -292.35 Million | -447 Thousand | -317.72 Million |
| Cash at beginning of period | 60.57 Million | 127.1 Million | 148.01 Million | 218.04 Million | 133.54 Million | 69.63 Million |
| Cash at end of period | 74.67 Million | 60.57 Million | 127.1 Million | 127.1 Million | 149.58 Million | 133.54 Million |
| Capital Expenditure | -4.78 Million | -2.15 Million | -2.23 Million | -12.93 Million | -2.06 Million | -5.85 Million |
| Effect of forex changes on cash | - | - | - | -75 Thousand | - | - |
| Net cash flow / Change in cash | 14.1 Million | -66.53 Million | -20.9 Million | -90.93 Million | 16.03 Million | 63.91 Million |
| Free Cash Flow | -96 Million | -115.77 Million | -100.89 Million | -370.93 Million | -89.43 Million | -119.01 Million |
PANACEABIO
6301
8898
O
5133
PES